Heron Therapeutics Inc (NASDAQ:HRTX)

41.35
Delayed Data
As of Jun 22
 +1.40 / +3.50%
Today’s Change
12.70
Today|||52-Week Range
42.05
+128.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.3B

Company Description

Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Contact Information

Heron Therapeutics, Inc.
4242 Campus Point Court
San Diego California 92121
P:(858) 251-4400
Investor Relations:
(581) 251-4447

Employees

Shareholders

Other institutional63.49%
Mutual fund holders49.32%
Individual stakeholders14.94%

Top Executives

Barry D. QuartChief Executive Officer & Director
Robert H. RosenPresident & Director
Robert E. HoffmanChief Financial Officer & Senior VP-Finance
Thomas B. OttoboniSVP-Pharmaceutical, Research & Development
Paul BlakeChief Medical Officer